33. Share incentive plans
(a) Cost of share-based compensation
2022 US$m | 2021 US$m | |
Share awards | 142 | 99 |
Share options | 7 | 7 |
Expense recognised (all equity-settled) | 149 | 106 |
Charge for associated social security obligations | 9 | 5 |
Total expense recognised in the Group income statement | 158 | 111 |
The Group has a number of equity-settled, share-based employee incentive plans. Further information on share award arrangements is given in note 33(b). As the numbers of share options granted or outstanding and the related charge to the Group income statement are not significant, no further disclosures are included in these financial statements.
(b) Share awards
(i) Summary of arrangements and performance conditions
There are three plans under which share awards are currently granted – the two Experian Co-investment Plans (the CIP) and the Experian Performance Share Plan (the PSP). Awards typically take the form of a grant of free shares which vest over a service period of three years, with a maximum term generally of the same length, and are settled by share distribution. The assumption at grant date for employee departures prior to vesting is 20% for certain unconditional awards, which are only made under the PSP. Other details in respect of conditional awards are given below.
During the year ended 31 March 2021, a one-off award was made under the PSP to employees who are not eligible to participate in existing share award schemes. These awards had no service or performance conditions attached and vested immediately. Participants who hold the shares received for three years will be entitled to receive two matching shares for each share they originally received. The grant date assumption is that 30% of these matching awards will not vest.
CIP
For the purposes of IFRS 2, the grant date for these plans is the start of the financial year in which performance is assessed. This is before the number of shares to be awarded is determined but the underlying value of the award is known, subject to the outcome of the performance condition. The value of awarded shares reflects the performance outcome assumed at the date of their issue to participants and is recognised over a four-year period.
The range of performance conditions for awards under these plans is set out below. The Profit performance condition requires adjusted Benchmark EPS growth at the stated percentages over a three-year period. The cumulative Benchmark operating cash flow performance condition (the Cash flow condition) is based on cumulative Benchmark operating cash flow over a three-year period. The period of assessment commences at the beginning of the financial year of grant. These are not market-based performance conditions as defined by IFRS 2.
PSP
The range of Profit performance conditions for conditional awards under this plan is the same as those for the CIP described above. The Return on Capital Employed condition (ROCE condition) requires average ROCE over the period at the percentages stated below. Both these conditions are not market-based performance conditions as defined by IFRS 2 and are also measured over a three-year period commencing at the beginning of the financial year of grant.
The TSR performance condition is considered a market-based performance condition as defined by IFRS 2. In valuing the awarded shares, TSR is evaluated using a Monte Carlo simulation, with historic volatilities and correlations for comparator companies measured over the three-year period preceding valuation and an implied volatility for Experian plc ordinary shares.
Year ended | 31 March 2022 | 31 March 2021 | 31 March 2020 | |||||
CIP | PSP | CIP | PSP | CIP | PSP | |||
Profit condition: | ||||||||
Proportion of awards subject to condition | 50% | 50% | 50% | 50% | 50% | 50% | ||
Minimum payout requirement | 5% per annum | 5% per annum | 3% per annum | 3% per annum | 5% per annum | 5% per annum | ||
Target payout requirement | 7% per annum | 7% per annum | 4% per annum | 4% per annum | 6% per annum | 6% per annum | ||
Maximum payout requirement | 10% per annum | 10% per annum | 7% per annum | 7% per annum | 9% per annum | 9% per annum | ||
Assumed outcome at grant date | 66.7% | 66.7% | 77.8% | 77.8% | 66.7% | 66.7% | ||
Cash flow condition: | ||||||||
Proportion of awards subject to condition | 50% | 50% | 50% | |||||
Minimum payout requirement | US$4.0bn | US$3.7bn | US$3.7bn | |||||
Target payout requirement | US$4.2bn | US$3.8bn | US$3.8bn | |||||
Maximum payout requirement | US$4.4bn | US$4.1bn | US$4.1bn | |||||
Assumed outcome at grant date | 64.5% | 77.8% | 77.2% | |||||
ROCE condition: | ||||||||
Proportion of awards subject to condition | 25% | 25% | 25% | |||||
Minimum payout requirement | 14.5 % per annum | 14.5% per annum | 14.5% per annum | |||||
Target payout requirement | 15.4 % per annum | 15.4% per annum | 15.4% per annum | |||||
Maximum payout requirement | 16.0 % per annum | 16.0% per annum | 16.0% per annum | |||||
Assumed outcome at grant date | 72% | 83% | 75% | |||||
TSR condition: | ||||||||
Proportion of awards subject to condition | 25% | 25% | 25% | |||||
Assumed outcome at grant date | 61.8% | 61.8% | 61.8% |
(ii) Information on share grant valuations
Share grants are valued by reference to the market price on the day of award, with no modification for dividend distributions or other factors, as participants are entitled to dividend distributions on awarded shares. Market-based performance conditions are included in the fair value measurement on the grant date and are not revised for actual performance. Awards granted in the year ended 31 March 2022 had a weighted average fair value per share of £27.25 (2021: £26.84).
(iii) Share awards outstanding
2022 million | 2021 million | |
At 1 April | 10.9 | 12.2 |
Grants | 4.6 | 4.1 |
Forfeitures | (0.8) | (0.5) |
Lapse of awards | (0.3) | (0.3) |
Vesting | (3.3) | (4.6) |
At 31 March | 11.1 | 10.9 |
Analysis by plan: | ||
CIP | 3.6 | 3.5 |
PSP – conditional awards | 2.7 | 3.0 |
PSP – unconditional awards | 4.8 | 4.4 |
At 31 March | 11.1 | 10.9 |